National Business Parks has finalized a new lease with Advaxis, a publicly traded clinical stage biotechnology company focused on developing cancer immunotherapies.  With three products in clinical development and a variety of pre-clinical products, the company’s research focuses on using the body’s natural immune system to redirect the immune response to kill cancer.  Advaxis, a…

Read More